✦ LIBER ✦

Carboplatin/Pemetrexed/Bevacizumab in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Single-Institution Experience

✍ Scribed by Binu Malhotra; Tracey Evans; Jared Weiss; Beth Eaby; Susan Stonehouse-Lee; Victoria Sherry; Corey J. Langer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness of bevacizumab- and pemetr

✍ Nuijten, Mark; Heigener, David F.; Bischoff, Helge G.; Chouaid, Christos; Vergne 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Treatment Rationale and Study Design for

✍ Ralph G. Zinner; Scott B. Saxman; Guangbin Peng; Matthew J. Monberg; Waldo I. Or 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 122 KB

Pharmacogenetic study of patients with a

✍ Tiseo, Marcello; Giovannetti, Elisa; Tibaldi, Carmelo; Camerini, Andrea; Di Cost 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Phase II Trial of Bevacizumab plus Pemet

✍ C. Dalsania; A. Hageboutros; E. Harris; K. Krieger; C. Vora; J.P. Stevenson 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 442 KB

Pemetrexed and carboplatin followed by p

✍ Isamu Okamoto, Keisuke Aoe, Terufumi Kato, Yukio Hosomi, Akira Yokoyama, Fumio I 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 294 KB

Bevacizumab combined with pemetrexed plu

✍ Santoro, Armando; Hillerdal, Gunnar N.; Hoeffken, Gert; Favaretto, Adolfo; Carri 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 596 KB